7 assets in Yolk Sac Tumor

Therapeutic assets addressing Yolk Sac Tumor, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Nivolumab Yolk Sac Tumor	Instituto do Cancer do Estado de São Paulo	P2	CCC (53)
21.15.gpc3-car t cells Yolk Sac Tumor	Baylor College of Medicine	P1	CC (43)
Bgb-B2033 Yolk Sac Tumor	BeOne Medicines	P1	CC (43)
Care T Cells Yolk Sac Tumor	Baylor College of Medicine	P1	CC (43)
Catch T Cells Yolk Sac Tumor	Baylor College of Medicine	P1	CC (43)
Sc-Car.Gpc3Xil15.21 Car T Cells Yolk Sac Tumor	Seattle Children's Hospital	P1	CC (43)
Tislelizumab Yolk Sac Tumor	BeOne Medicines	P1	CC (43)